Key result
Among 4,727 hypertensive patients admitted with acute stroke, pre-admission use of RAS blockers (54%) and beta-blockers (43%) increased significantly from 2004 to 2010 (p<0.001 for both).
Observational (n=6,279)
Yes
p-value: p=<0.001
In an Israeli national stroke registry from 2004-2010, the pre-admission use of RAS blockers and beta-blockers increased while diuretic use decreased among hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Changing pre-admission antihypertensive patterns in stroke merit surveillance; leaves open outcome associations in observational data.
Koifman et al. (2014) conducted an observational in Acute stroke (n=6,279). Antihypertensive therapy vs. Temporal trends (2004-2010) was evaluated on Temporal trends of antihypertensive therapy utilization before hospital admission (p=<0.001). Among 4,727 hypertensive patients admitted with acute stroke, pre-admission use of RAS blockers (54%) and beta-blockers (43%) increased significantly from 2004 to 2010 (p<0.001 for both).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: